Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies

Life Sciences

Volumn 32, Issue 16, 1983, Pages 1849-1856

  Le Fur, G ^a   Guilloux, F ^a   Rufat, P ^a   Benavides, J ^a   Uzan, A ^a   Renault, C ^a   Dubroeucq, M C ^a   Gueremy C ^a  

^a PHARMUKA Laboratories ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

4' CHLORODIAZEPAM; 4' CHLORODIAZEPAM H 3; CLONAZEPAM; DIAZEPAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG ANTAGONISM; DRUG COMPARISON; DRUG RECEPTOR BINDING; HEART; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RADIOCHROMATOGRAPHY;

ANIMALS; BENZODIAZEPINONES; BRAIN; CLONAZEPAM; DIAZEPAM; ISOQUINOLINES; KIDNEY; KINETICS; MALE; MICE; MYOCARDIUM; RECEPTORS, CELL SURFACE; RECEPTORS, GABA-A;

ANIMALIA;

EID: 0020533010     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(83)90063-2     Document Type: Article

References (10)